Related Experiment Videos
Heterogeneity in the beta-endorphin immunoreactivity response to electroconvulsive therapy
E A Young1, L Grunhaus, R F Haskett
1Mental Health Research Institute, University of Michigan, Ann Arbor 148109.
Archives of General Psychiatry
|June 1, 1991
Summary
Electroconvulsive therapy (ECT) activates the stress response, releasing beta-endorphins. Individual patient responses vary, with some showing more release during initial ECT and others during later treatments.
Area of Science:
- Neuroscience
- Endocrinology
- Psychiatry
Background:
- Electroconvulsive therapy (ECT) is known to activate the hypothalamic-pituitary-adrenal (HPA) axis.
- This activation leads to the release of beta-endorphin from the anterior pituitary corticotrophs.
Purpose of the Study:
- To investigate the pattern of plasma beta-endorphin immunoreactivity response to initial versus final electroconvulsive therapy treatments.
- To explore factors influencing individual variations in beta-endorphin release during ECT.
Main Methods:
- Plasma beta-endorphin immunoreactivity levels were measured in patients undergoing electroconvulsive therapy.
- Patient data including age, sex, treatment parameters (unilateral vs. bilateral, waveform), and medication use were collected.
- Seizure duration during initial and final treatments was recorded and analyzed.
Main Results:
- As a group, patients showed similar beta-endorphin immunoreactivity responses between initial and final ECT sessions.
- Approximately half of the patients exhibited a greater beta-endorphin release with the first seizure compared to the last, while the other half showed the opposite pattern.
- This individual variability was not associated with age, sex, treatment laterality, waveform, or concomitant medications.
- Patients maintaining constant seizure duration throughout ECT showed increased beta-endorphin release in final treatments.
- Patients with decreasing seizure duration demonstrated a reduced beta-endorphin response in final treatments.
Conclusions:
- While the overall group response of beta-endorphin release to ECT is consistent, individual patient responses vary significantly.
- Seizure duration appears to be a key factor influencing the pattern of beta-endorphin release during a course of electroconvulsive therapy.
- Further research may elucidate other factors contributing to differential beta-endorphin responses in ECT patients.